Quicker Remission With Tofacitinib vs Vedolizumab in Ulcerative Colitis: Study ...Middle East

Tofacitinib achieves higher clinical and biochemical remission rates than vedolizumab for patients with anti-TNF-exposed ulcerative colitis, although the effect diminishes over time, say Dutch scientists. Medscape Medical News

Hence then, the article about quicker remission with tofacitinib vs vedolizumab in ulcerative colitis study was published today ( Monday 11/07/2022 - 10:48 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Quicker Remission With Tofacitinib vs Vedolizumab in Ulcerative Colitis: Study )

Also on site :

• The Iran War Hits Your Pocket
• This 'Chic' Shacket Is 'Perfect for Layering,' and It's on Sale for $17 During Amazon’s Big Spring Sale
• The world’s consumers are ready for robotaxis. James Peng of Pony AI wants to make sure they’re riding in his